New Strain May Make a Common Bacterial Illness More Severe

Article

Illness related to C. difficile, a bacterium commonly found in hospitals, is becoming more widespread, more severe, and harder to treat, reports the April 2007 issue of Harvard Womens Health Watch. Health experts are worried that a new, more virulent strain may be to blame.

Certain strains of C. difficile produce toxins that attack the cells lining the colon. Those strains can cause symptoms ranging from mild diarrhea to severe colitis if they enter the gastrointestinal tract of a person who is taking antibiotics. Although antibiotics kill off many types of harmful bacteria, they can also wipe out the good bugs in the large intestine that keep C. difficile in check.

Most people exposed to C. difficile will not get sick from it, nor will most people who take antibiotics. The risk is higher for patients who are older, spend more time in the hospital, and are treated for a longer period with antibiotics. You can help limit the spread if you learn the risk factors and take some precautions. The Harvard Womens Health Watch recommends these steps:

Wash your hands thoroughly after visiting a hospital. Use soap and water; alcohol-based hand gels do not kill C. difficile.

If youve been taking antibiotics and you develop watery diarrhea and abdominal pain, see your clinician right away.

Take antibiotics exactly as prescribed. They are of no use in treating colds and other viral diseases.

Sometimes you need to be in a hospital. But as soon as you feel well enough, ask if home healthcare is an option for you.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.